Cargando…
Ongoing trials on COVID-19 treatments: please, don’t forget Venous Thromboembolism!
Autores principales: | Zuin, Marco, Zuliani, Giovanni, Rigatelli, Gianluca, Roncon, Loris |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7775837/ https://www.ncbi.nlm.nih.gov/pubmed/33386562 http://dx.doi.org/10.1007/s11239-020-02366-3 |
Ejemplares similares
-
Corticosteroid therapy in COVID-19 patients: Don’t forget venous thromboembolism
por: Roncon, Loris, et al.
Publicado: (2021) -
Reduction of venous thromboembolic events in COVID-19 patients: Which role for IL-6 antagonists?
por: Zuin, Marco, et al.
Publicado: (2021) -
Age-adjusted d-dimer cut-off levels to exclude venous thromboembolism in COVID-19 patients
por: Zuin, Marco, et al.
Publicado: (2021) -
Fatigue as long-term consequence of ARDS in COVID-19 patients
por: Zuin, Marco, et al.
Publicado: (2021) -
Arterial hypertension and risk of death in patients with COVID-19 infection: Systematic review and meta-analysis
por: Zuin, Marco, et al.
Publicado: (2020)